Dose-dependent decreases in EBOVΔVP30 infection were also observed for all three IFNs when treatment was extended to 24 h (Figure 3B), with IFN-β and IFN-λ both conferring similar levels of inhibition. The gene discussed is IFNB1; the disease is infection.